Terug
Dagbereik
€ 62,80
€ 64,66
52-Weeksbereik
€ 14,80
€ 69,35
Volume
966.788
50D / 200D Gem.
€ 56,68
/
€ 39,90
Vorige Slotkoers
€ 64,96
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -33,5 | 0,3 |
| P/B | 7,2 | 2,9 |
| ROE % | -21,7 | 3,7 |
| Net Margin % | -3985,0 | 3,8 |
| Rev Growth 5Y % | -21,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 79,00
+23.7%
Low: € 70,00
High: € 93,00
Forward WPA
-€ 2,42
Omzet Sch.
15 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,52
€ 0,80 – € 17,44
|
1,4 B | 3 |
| FY2029 |
€ 3,22
€ 0,39 – € 8,61
|
910 M | 3 |
| FY2028 |
€ 0,22
-€ 1,72 – € 3,82
|
460 M | 9 |
Belangrijkste Punten
Revenue declined -20,97% annually over 5 years
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -132,48M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 275,67%
Capital efficient — spends only 3,32% of revenue on capex
Groei
Revenue Growth (5Y)
-20,97%
Revenue (1Y)254,70%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-21,67%
ROIC-18,84%
Net Margin-3985,02%
Op. Margin-4722,13%
Veiligheid
Debt / Equity
0,01
Current Ratio24,63
Interest Coverage0,00
Waardering
P/E Ratio
-33,48
P/B Ratio7,16
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 254,70% | Revenue Growth (3Y) | 345,02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20,97% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,04M | Net Income (TTM) | -161,00M |
| ROE | -21,67% | ROA | -20,34% |
| Gross Margin | -15,02% | Operating Margin | -4722,13% |
| Net Margin | -3985,02% | Free Cash Flow (TTM) | -132,48M |
| ROIC | -18,84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 24,63 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -33,48 | P/B Ratio | 7,16 |
| P/S Ratio | 1334,24 | PEG Ratio | -0,42 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,39B | Enterprise Value | 5,36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,04M | 1,14M | 204.000,0 | 191.000,0 | 10,36M |
| Net Income | -161,00M | -88,04M | -48,61M | -35,44M | -12,84M |
| EPS (Diluted) | -2,08 | -1,41 | -1,02 | -0,66 | -0,28 |
| Gross Profit | -607.000,0 | 1,14M | 204.000,0 | 176.000,0 | 10,35M |
| Operating Income | -190,77M | -114,67M | -55,45M | -35,25M | -12,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 791,59M | 754,80M | 199,30M | 147,75M | 58,69M |
| Total Liabilities | 38,99M | 21,42M | 14,51M | 22,57M | 18,44M |
| Shareholders' Equity | 752,60M | 733,38M | 184,79M | 125,18M | 40,25M |
| Total Debt | 7,02M | 238.000,0 | 1,03M | 15,94M | 15,13M |
| Cash & Equivalents | 32,49M | 257,07M | 8,27M | 88,14M | 53,61M |
| Current Assets | 759,48M | 754,21M | 194,12M | 147,21M | 58,41M |
| Current Liabilities | 30,84M | 21,37M | 14,25M | 15,43M | 5,98M |